Table 1. Biosimilars Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Biosimilars Drug Market Restraints

Table 3. Biosimilars Drug Market Trends

Table 4. Biosimilars Drug Industry Policy

Table 5. Global Biosimilars Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Biosimilars Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Biosimilars Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Biosimilars Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Biosimilars Drug Manufacturers Product Type

Table 10. China Biosimilars Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Biosimilars Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Biosimilars Drug Upstream (Raw Materials)

Table 13. Global Biosimilars Drug Typical Customers

Table 14. Biosimilars Drug Typical Distributors

Table 15. By Type, Global Biosimilars Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Biosimilars Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Biosimilars Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Biosimilars Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Biosimilars Drug Revenue Market Share, 2018-2029

Table 22. Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 23. Qilu Pharmaceutical Company Profile and Main Business

Table 24. Qilu Pharmaceutical Biosimilars Drug Models, Specifications and Application

Table 25. Qilu Pharmaceutical Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 26. Qilu Pharmaceutical Recent Developments

Table 27. Bio-Thera Company Information, Head Office, Market Area and Industry Position

Table 28. Bio-Thera Company Profile and Main Business

Table 29. Bio-Thera Biosimilars Drug Models, Specifications and Application

Table 30. Bio-Thera Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 31. Bio-Thera Recent Developments

Table 32. Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position

Table 33. Zhejiang Hisun Company Profile and Main Business

Table 34. Zhejiang Hisun Biosimilars Drug Models, Specifications and Application

Table 35. Zhejiang Hisun Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 36. Zhejiang Hisun Recent Developments

Table 37. Shanghai Henlius Company Information, Head Office, Market Area and Industry Position

Table 38. Shanghai Henlius Company Profile and Main Business

Table 39. Shanghai Henlius Biosimilars Drug Models, Specifications and Application

Table 40. Shanghai Henlius Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 41. Shanghai Henlius Recent Developments

Table 42. Innovent Biologics Company Information, Head Office, Market Area and Industry Position

Table 43. Innovent Biologics Company Profile and Main Business

Table 44. Innovent Biologics Biosimilars Drug Models, Specifications and Application

Table 45. Innovent Biologics Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 46. Innovent Biologics Recent Developments

Table 47. Jiangsu Hengrui Company Information, Head Office, Market Area and Industry Position

Table 48. Jiangsu Hengrui Company Profile and Main Business

Table 49. Jiangsu Hengrui Biosimilars Drug Models, Specifications and Application

Table 50. Jiangsu Hengrui Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 51. Jiangsu Hengrui Recent Developments

Table 52. Gan&Lee Company Information, Head Office, Market Area and Industry Position

Table 53. Gan&Lee Company Profile and Main Business

Table 54. Gan&Lee Biosimilars Drug Models, Specifications and Application

Table 55. Gan&Lee Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 56. Gan&Lee Recent Developments

Table 57. Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position

Table 58. Tonghua Dongbao Company Profile and Main Business

Table 59. Tonghua Dongbao Biosimilars Drug Models, Specifications and Application

Table 60. Tonghua Dongbao Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 61. Tonghua Dongbao Recent Developments

Table 62. United Laboratory Company Information, Head Office, Market Area and Industry Position

Table 63. United Laboratory Company Profile and Main Business

Table 64. United Laboratory Biosimilars Drug Models, Specifications and Application

Table 65. United Laboratory Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 66. United Laboratory Recent Developments

Table 67. 3SBIO Company Information, Head Office, Market Area and Industry Position

Table 68. 3SBIO Company Profile and Main Business

Table 69. 3SBIO Biosimilars Drug Models, Specifications and Application

Table 70. 3SBIO Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 71. 3SBIO Recent Developments

Table 72. Luye Pharma Company Information, Head Office, Market Area and Industry Position

Table 73. Luye Pharma Company Profile and Main Business

Table 74. Luye Pharma Biosimilars Drug Models, Specifications and Application

Table 75. Luye Pharma Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 76. Luye Pharma Recent Developments

Table 77. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 78. Celltrion Company Profile and Main Business

Table 79. Celltrion Biosimilars Drug Models, Specifications and Application

Table 80. Celltrion Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 81. Celltrion Recent Developments

Table 82. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 83. Pfizer Company Profile and Main Business

Table 84. Pfizer Biosimilars Drug Models, Specifications and Application

Table 85. Pfizer Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 86. Pfizer Recent Developments

Table 87. Novartis Company Information, Head Office, Market Area and Industry Position

Table 88. Novartis Company Profile and Main Business

Table 89. Novartis Biosimilars Drug Models, Specifications and Application

Table 90. Novartis Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 91. Novartis Recent Developments

Table 92. Dr Reddy’s Company Information, Head Office, Market Area and Industry Position

Table 93. Dr Reddy’s Company Profile and Main Business

Table 94. Dr Reddy’s Biosimilars Drug Models, Specifications and Application

Table 95. Dr Reddy’s Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 96. Dr Reddy’s Recent Developments

Table 97. Celgen Biopharma Company Information, Head Office, Market Area and Industry Position

Table 98. Celgen Biopharma Company Profile and Main Business

Table 99. Celgen Biopharma Biosimilars Drug Models, Specifications and Application

Table 100. Celgen Biopharma Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 101. Celgen Biopharma Recent Developments

Table 102. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 103. Eli Lilly Company Profile and Main Business

Table 104. Eli Lilly Biosimilars Drug Models, Specifications and Application

Table 105. Eli Lilly Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 106. Eli Lilly Recent Developments

Table 107. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 108. Sanofi Company Profile and Main Business

Table 109. Sanofi Biosimilars Drug Models, Specifications and Application

Table 110. Sanofi Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 111. Sanofi Recent Developments

Table 112. Geropharm Company Information, Head Office, Market Area and Industry Position

Table 113. Geropharm Company Profile and Main Business

Table 114. Geropharm Biosimilars Drug Models, Specifications and Application

Table 115. Geropharm Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 116. Geropharm Recent Developments

Table 117. Biocon Company Information, Head Office, Market Area and Industry Position

Table 118. Biocon Company Profile and Main Business

Table 119. Biocon Biosimilars Drug Models, Specifications and Application

Table 120. Biocon Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 121. Biocon Recent Developments

Table 122. Wockhardt Company Information, Head Office, Market Area and Industry Position

Table 123. Wockhardt Company Profile and Main Business

Table 124. Wockhardt Biosimilars Drug Models, Specifications and Application

Table 125. Wockhardt Biosimilars Drug Revenue and Gross Margin, 2018-2023

Table 126. Wockhardt Recent Developments

List of Figure

Figure 1. Biosimilars Drug Picture

Figure 2. Global Biosimilars Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Biosimilars Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Biosimilars Drug Market Share of Global

Figure 5. Global Biosimilars Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Biosimilars Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Biosimilars Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Biosimilars Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Biosimilars Drug Industry Chain

Figure 10. Monoclonal Antibodies

Figure 11. Insulin

Figure 12. Others

Figure 13. By Type, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Biosimilars Drug Revenue Market Share, 2018-2029

Figure 15. Hospital

Figure 16. Retail Pharmacy

Figure 17. Other

Figure 18. By Application, Global Biosimilars Drug Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Biosimilars Drug Revenue Market Share, 2018-2029

Figure 20. By Region, Global Biosimilars Drug Revenue Market Share, 2018-2029

Figure 21. North America Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Biosimilars Drug Revenue Market Share, 2018-2023

Figure 23. Europe Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Biosimilars Drug Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Biosimilars Drug Revenue Market Share, 2018-2023

Figure 27. South America Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Biosimilars Drug Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Biosimilars Drug Market Share, 2018-2023

Figure 32. By Type, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 34. Europe Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Biosimilars Drug Market Share, 2018-2023

Figure 36. By Type, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 38. China Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Biosimilars Drug Market Share, 2018-2023

Figure 40. By Type, China Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 42. Japan Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Biosimilars Drug Market Share, 2018-2023

Figure 44. By Type, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Biosimilars Drug Market Share, 2018-2023

Figure 48. By Type, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Biosimilars Drug Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 54. India Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Biosimilars Drug Market Share, 2018-2023

Figure 56. By Type, India Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Biosimilars Drug Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Biosimilars Drug Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches